Trump, Hims and Marty Makary
Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans ...
Trump taps a Fox News personality, a surgeon and a former Congressman to lead public health agencies
Makary, a professor at Johns Hopkins University, is the latest in a string of Trump nominees who have declared the U.S. health system “broken," vowing a shakeup. As part of a flurry of ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA. Makary served as the editor-in-chief ...
(NEW YORK) — President Donald Trump said he wants Marty Makary, a Johns Hopkins surgeon and author who argued against pandemic lockdowns, to lead the U.S. Food and Drug Administration.
President-elect Donald Trump on Friday nominated Dr. Marty Makary to lead the Food and Drug Administration, selecting a surgeon and author who gained national attention for opposing vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback